~~<i id='A58F6F64E1'><strike id='A58F6F64E1'><tt id='A58F6F64E1'><pre id='A58F6F64E1'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

focus

author：entertainment 2025-09-30 23:05:49 - browse：6199

It’s that time of the year again when I recognize the Best Biopharma CEO of the year.

This year’s selection is so deservingly obvious that I won’t fabricate suspense by starting with an honor roll of runners-up. More on those high-achieving folks later. Let’s get right to the main course: David Ricks of Eli Lillyis the runaway, rock star, who-else-could-it-be Best Biopharma CEO of 2023.

What an incredible year it’s been for Ricks and the Lilly executive team who helped him achieve so much. My colleague Matt Herper wrote earlier this year about the “dynamic duo” of Ricks and Chief Scientific Officer Dan Skovronsky.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Will.i.am, Britney Spears release new single, 'Mind Your Business'

hotspot

knowledge

focus

hotspot

explore

Wikipedia

Greco-Romansurgicalinstruments.WellcomeImagesTheroadtomodernmedicinehasbeenalongone,anddoctorshaveco

WSS

NIH chief: government has fallen behind pharma on clinical trials

Why an extreme heat and wildfire smoke combination can be so dangerous

Publishing genetic code of viruses could cause disaster

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

Weight loss drugs should be covered by insurers, AMA says

Will.i.am, Britney Spears release new single, 'Mind Your Business'

entertainment

focus

hotspot

As demand for Covid shots wanes, Moderna seeks its next success

After decades in use, heart stents finally beat placebo

23andMe had bad news about my health. I wish a person had delivered it

CDC backtracks, saying fully vaccinated people can go maskless indoors

How one medical school became remarkably diverse

AbbVie dramatically boosts its spending on lobbying

Alkermes shareholders re

FDA cancer chief on how to get things done: ‘Don’t tell anybody'

As demand for Covid shots wanes, Moderna seeks its next success

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

knowledge

Review: 'Barbie' will hit you like a shot in the heart

Court strikes down limits on filming of police in Arizona

Today's health inequities arise from racist U.S. history, say experts

Hyaluronic acid injections don’t help knee osteoarthritis, study finds

What is STAT's opinion section for?

Marvel Studios reveals new trailer for 'The Marvels': Watch here

focus

hotspot

explore

Wikipedia